Cetera Investment Advisers’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.62M Sell
34,356
-4,087
-11% -$628K 0.01% 1432
2025
Q4
$6.69M Sell
38,443
-2,728
-7% -$498K 0.01% 1272
2025
Q3
$5.93M Buy
41,171
+9,709
+31% +$1.19M 0.01% 1302
2025
Q2
$3.17M Buy
31,462
+10,783
+52% +$824K 0.01% 1508
2025
Q1
$1.58M Buy
20,679
+10,525
+104% +$805K ﹤0.01% 1928
2024
Q4
$701K Buy
10,154
+1,321
+15% +$95.1K ﹤0.01% 2417
2024
Q3
$645K Buy
8,833
+1,598
+22% +$118K ﹤0.01% 2447
2024
Q2
$485K Buy
+7,235
New +$281K ﹤0.01% 2619

Other funds holding INSM

Cetera Investment Advisers's INSM Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Insmed (INSM) stake by 11% in Q1 2026, selling an estimated $628K and leaving 34,356 shares worth $5.62M. The position accounts for 0.01% of the portfolio, ranked #1432.

Cetera Investment Advisers first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.69M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Cetera Investment Advisers held 34,356 shares of Insmed worth $5.62M as of Q1 2026.
  • Cetera Investment Advisers sold 4,087 Insmed shares in Q1 2026, an estimated $628K.
  • Insmed made up 0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #1432 holding.
  • Cetera Investment Advisers first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Cetera Investment Advisers's Insmed position peaked at $6.69M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.